Biodexa Pharmaceuticals (BDRX) Inventory (2015 - 2018)

Biodexa Pharmaceuticals has disclosed Inventory across 4 years of filings, most recently posting $809376.6 for Q4 2018.

• In Q4 2018, Inventory fell 35.22% year-over-year to $809376.6; the TTM figure through Dec 2018 stood at $809376.6 (down 35.22% YoY), while the FY2018 annual figure was $840066.8, down 30.7% from the prior year.
• Inventory came in at $809376.6 for Q4 2018 at Biodexa Pharmaceuticals, down from $1.4 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $1.4 million in Q2 2018 to a low of $696528.2 in Q4 2015.
• Average Inventory over 4 years is $1.1 million, with a median of $1.1 million recorded in 2016.
• Year-over-year, Inventory jumped 45.83% in 2016 and sank 35.22% in 2018.
• Over 4 years, Inventory stood at $696528.2 in 2015, then surged by 45.83% to $1.0 million in 2016, then gained by 23.0% to $1.2 million in 2017, then slumped by 35.22% to $809376.6 in 2018.
• Per Business Quant data, the three most recent Inventory figures were $809376.6 in Q4 2018, $1.4 million in Q2 2018, and $1.2 million in Q4 2017.